dc.contributor.author | Antipova, Alena A. | |
dc.contributor.author | Tamayo, Pablo | |
dc.contributor.author | Golub, Todd R. | |
dc.date.accessioned | 2010-10-12T14:09:51Z | |
dc.date.available | 2010-10-12T14:09:51Z | |
dc.date.issued | 2002-11 | |
dc.date.submitted | 2002-09 | |
dc.identifier.issn | 1465-6906 | |
dc.identifier.uri | http://hdl.handle.net/1721.1/59013 | |
dc.description.abstract | Background: One of the factors limiting the number of genes that can be analyzed on high-density oligonucleotide arrays is that each transcript is probed by multiple oligonucleotide probes. To reduce the number of probes required for each gene, a systematic approach to choosing the most representative probes is needed. A method is presented for reducing the number of probes per gene while maximizing the fidelity to the original array design. Results: The methodology has been tested on a dataset comprising 317 Affymetrix HuGeneFL GeneChips. The performance of the original and reduced probe sets was compared in four cancer-classification problems. The results of these comparisons show that reduction of the probe set by 95% does not dramatically affect performance, and thus illustrate the feasibility of substantially reducing probe numbers without significantly compromising sensitivity and specificity of detection. Conclusions: The strategy described here is potentially useful for designing small, limited-probe genome-wide arrays for screening applications. | en_US |
dc.publisher | BioMed Central Ltd | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1186/gb-2002-3-12-research0073 | en_US |
dc.rights | Creative Commons Attribution | en_US |
dc.source | BioMed Central Ltd | en_US |
dc.title | A strategy for oligonucleotide microarray probe reduction | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Genome Biology. 2002 Nov 25;3(12):research0073-research0073.4 | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Chemistry | en_US |
dc.contributor.department | Whitehead Institute for Biomedical Research | en_US |
dc.contributor.mitauthor | Antipova, Alena A. | |
dc.contributor.mitauthor | Tamayo, Pablo | |
dc.contributor.mitauthor | Golub, Todd R. | |
dc.relation.journal | Genome Biology | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.pmid | 12537562 | |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dc.date.updated | 2010-09-03T16:07:02Z | |
dc.language.rfc3066 | en | |
dc.rights.holder | Antipova et al.; licensee BioMed Central Ltd. | |
dspace.orderedauthors | Antipova, Alena A; Tamayo, Pablo; Golub, Todd R | en |
mit.license | PUBLISHER_CC | en_US |
mit.metadata.status | Complete | |